First- and second-line bevacizumab in addition to chemotherapy for metastatic colorectal cancer: a United States-based cost-effectiveness analysis (Q35563197)
Jump to navigation
Jump to search
scientific article published on 17 February 2015
Language | Label | Description | Also known as |
---|---|---|---|
English | First- and second-line bevacizumab in addition to chemotherapy for metastatic colorectal cancer: a United States-based cost-effectiveness analysis |
scientific article published on 17 February 2015 |
Statements
1 reference
First- and second-line bevacizumab in addition to chemotherapy for metastatic colorectal cancer: a United States-based cost-effectiveness analysis (English)
1 reference
Daniel A Goldstein
1 reference
Qiushi Chen
1 reference
Turgay Ayer
1 reference
David H Howard
1 reference
Joseph Lipscomb
1 reference
Bassel F El-Rayes
1 reference
Christopher R Flowers
1 reference
17 February 2015
1 reference
1 reference
33
1 reference
10
1 reference
1112-1118
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference
1 reference